Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Masanori Sugiura is active.

Publication


Featured researches published by Masanori Sugiura.


Inflammation Research | 1994

EFFECT OF THE NOVEL RADICAL SCAVENGER AD0261 ON LYMPHOCYTE ACTIVATION

Masanori Sugiura; J. Wada; Shigeki Kuwahara; Masahiko Kajii; Naoki Sugiyama; Hiroko Nishimura; Chikara Fukaya; K. Yamanouchi; Kazumasa Yokoyama

A recent investigation has indicated that reactive oxygen species (ROS) may play an important role in the activation of lymphocytes. The main aim of the present study is to find out what effect on lymphocyte activation is attributable to radical scavengers (RSs). AD0261 (AD) is a novel RS which displays strong inhibitory action on the generation of lipid peroxides and superoxide anions. This compound has been shown to be effective in inhibiting tritiated thymidine ([3H]TdR) incorporation into, IL-2 release from and IL-2 receptor (Rc) expression on Con A-stimulated mouse spleen cells and PHA-P-stimulated lymphocytes of human peripheral blood, IC50 values being in the range 1–10 μM. It also inhibited erythema formation elicited by transferring PHA-P-stimulated lymphocytes into guinea pigs (30–40% inhibition at 10 μM,p<0.05). Further study showed that the activity of ornithine decarboxylase (ODC), which is a critical enzyme for cell proliferation, was inhibited by AD in a dose-dependent manner (IC50=1.0 μM). In summary, AD would seem to affect the lymphocyte activation by inhibiting ODC activity, probably through the action of ROS trapping.


Archive | 1985

A lipoxygenase inhibitor

Kazumasa Yokoyama; Chikara Fukaya; Masanori Sugiura; Youichiro Naito; Masayuki Nishida; Tadakazu Suyama


Archive | 1994

Triazole derivative and pharmaceutical use thereof

Fumihiko Akahoshi; Takehiro Okada; Shinji Takeda; Youichiro Naito; Chikara Fukaya; Shigeki Kuwahara; Masahiko Kajii; Hiroko Nishimura; Masanori Sugiura


Chemical & Pharmaceutical Bulletin | 1989

Inhibitory Activities and Inhibition Specificities of Caffeic Acid Derivatives and Related Compounds toward 5-Lipoxygenase

Masanori Sugiura; Youichiro Naito; Yasunari Yamaura; Chikara Fukaya; Kazumasa Yokoyama


Journal of Medicinal Chemistry | 1994

Synthesis and topical antiinflammatory and antiallergic activities of antioxidant o-aminophenol derivatives.

Naoki Sugiyama; Fumihiko Akahoshi; Shigeki Kuwahara; Masahiko Kajii; Yoshiko Sakaue; Haruko Yakumaru; Masanori Sugiura; Chikara Fukaya


Chemical & Pharmaceutical Bulletin | 1997

Novel Histamine H3 Receptor Antagonists: Synthesis and Evaluation of Formamidine and S-Methylisothiourea Derivatives.

Tomokazu Goto; Hiroshi Sakashita; Kazuki Muarkami; Masanori Sugiura; Takao Kondo; Chikara Fukaya


Archive | 1988

Bis-S-alkylbenzene derivatives

Youichiro Naito; Yasunari Yamaura; Masanori Sugiura; Chikara Fukaya; Kazumasa Yokoyama


Archive | 1992

Substituted or unsubstituted benzhydryl heteroalkyl-substituted aminophenol compounds and pharmaceutical compositions thereof

Naoki Sugiyama; Fumihiko Akaboshi; Haruko Yakumaru; Tomokazu Gotoh; Masanori Sugiura; Shigeki Kuwahara; Masahiko Kajii; Yoshiko Tanaka; Takao Kondoh; Chikara Fukaya


Archive | 1992

Novel aminophenol derivatives and pharmaceutical compositions thereof

Naoki Sugiyama; Fumihiko Akaboshi; Haruko Yakumaru; Tomokazu Gotoh; Masanori Sugiura; Shigeki Kuwahara; Masahiko Kajii; Yoshiko Tanaka; Takao Kondoh; Chikara Fukuya


Archive | 1991

TREATING AGENT FOR OSTEOPOROSIS

Takuji Hanamura; Yasushi Matsuoka; Ryoko Ri; Masanori Sugiura; 杉浦 正典; 良子 李; 靖史 松岡; 卓司 花村

Collaboration


Dive into the Masanori Sugiura's collaboration.

Researchain Logo
Decentralizing Knowledge